BCVA can remain deceptively stable until late RP and becomes insensitive at profound vision loss, motivating ...

VG801, an investigational gene therapy for ABCA4-associated retinal disease, including Stargardt disease, is being evaluated in an ongoing Phase 1/2 first-in-human clinical trial assessing safety, ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS – RightEye launched the Functional Vision EyeQ for measuring dynamic vision skills, here at SECO.

July 15, 2009 — Current evidence is insufficient to determine the balance of benefits and harms of visual acuity screening for the improvement of outcomes in older adults, according to a position ...

Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

Online eyewear and vision care company Visibly announced it had received FDA 510(k) clearance for its at-home vision test. The Visibly Digital Acuity Product uses a touchscreen mobile device, like a ...

AUCKLAND, New Zealand--(BUSINESS WIRE)--Objective Acuity has reached a significant milestone in its development of the world’s first, objective, visual acuity test. It has successfully concluded proof ...

Credit: Shutterstock. Individuals can complete the test in approximately 6 minutes, at which point the test results will be made available to an eye care professional. The Food and Drug Administration ...